Zentalis PharmaceuticalsL Stock Options
| ZNTL Stock | USD 11.77 0.80 6.36% |
Zentalis PharmaceuticalsL's option chain provides insight into all available option contracts written on Zentalis PharmaceuticalsL's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Zentalis PharmaceuticalsL's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Zentalis option contract.
In The Money vs. Out of Money Option Contracts on Zentalis PharmaceuticalsL
Analyzing Zentalis PharmaceuticalsL's in-the-money options over time can help investors to take a profitable long position in Zentalis PharmaceuticalsL regardless of its overall volatility. This is especially true when Zentalis PharmaceuticalsL's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Zentalis PharmaceuticalsL's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Zentalis PharmaceuticalsL's stock while costing only a fraction of its price.
Zentalis PharmaceuticalsL's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 88.99 with a put-to-call open interest ratio of 0.0 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 2. This yields a 0.0 put-to-call volume ratio. The Zentalis PharmaceuticalsL option chain provides detailed quote and price information for the current Zentalis PharmaceuticalsLlc option contracts. It shows all of Zentalis PharmaceuticalsL's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Zentalis PharmaceuticalsL's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Zentalis PharmaceuticalsL's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Zentalis PharmaceuticalsL's option, there is no secondary market available for investors to trade.
Zentalis PharmaceuticalsL Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Zentalis PharmaceuticalsL close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Zentalis PharmaceuticalsL's stock options are financial instruments that give investors the right to buy or sell shares of Zentalis PharmaceuticalsL common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Zentalis stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Zentalis PharmaceuticalsL's stock price goes up or down, the stock options follow.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Please note that buying 'in-the-money' options on Zentalis PharmaceuticalsL lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Zentalis PharmaceuticalsL's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Zentalis PharmaceuticalsL contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Zentalis Stock moves the wrong way.
The value of Total Stockholder Equity is estimated to slide to about 306.3 M. The value of Common Stock Total Equity is estimated to slide to about 50.4 KZentalis PharmaceuticalsL In The Money Call Balance
When Zentalis PharmaceuticalsL's strike price is surpassing the current stock price, the option contract against Zentalis PharmaceuticalsLlc stock is said to be in the money. When it comes to buying Zentalis PharmaceuticalsL's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Zentalis PharmaceuticalsLlc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Zentalis Current Options Market Mood
Zentalis PharmaceuticalsL's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Zentalis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Zentalis PharmaceuticalsL's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Zentalis PharmaceuticalsL's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Zentalis PharmaceuticalsL's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Zentalis contract
Base on the Rule 16, the options market is currently suggesting that Zentalis PharmaceuticalsLlc will have an average daily up or down price movement of about 5.56% per day over the life of the 2024-05-17 option contract. With Zentalis PharmaceuticalsL trading at USD 11.77, that is roughly USD 0.65. If you think that the market is fully incorporating Zentalis PharmaceuticalsL's daily price movement you should consider buying Zentalis PharmaceuticalsLlc options at the current volatility level of 88.99%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Zentalis |
Purchasing Zentalis PharmaceuticalsL options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Zentalis calls. Remember, the seller must deliver Zentalis PharmaceuticalsLlc stock to the call owner when a call is exercised.
Zentalis PharmaceuticalsL Option Chain
When Zentalis PharmaceuticalsL's strike price is surpassing the current stock price, the option contract against Zentalis PharmaceuticalsLlc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Zentalis PharmaceuticalsL's option chain is a display of a range of information that helps investors for ways to trade options on Zentalis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Zentalis. It also shows strike prices and maturity days for a Zentalis PharmaceuticalsL against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.5 | 0.978 | 0.0015 | 0 | 2024-05-17 | 7.4 - 11.1 | 0.0 | In |
Call | 2024-05-17 CALL at $5.0 | 0.9166 | 0.0138 | 0 | 2024-05-17 | 5.9 - 9.0 | 0.0 | In |
Call | 2024-05-17 CALL at $7.5 | 0.8824 | 0.035 | 0 | 2024-05-17 | 3.8 - 5.6 | 0.0 | In |
Call | 2024-05-17 CALL at $10.0 | 0.758 | 0.0876 | 9 | 2024-05-17 | 1.85 - 2.95 | 2.98 | In |
Call | 2024-05-17 CALL at $12.5 | 0.4508 | 0.1427 | 27 | 2024-05-17 | 0.35 - 1.3 | 1.35 | Out |
Call | 2024-05-17 CALL at $15.0 | 0.162 | 0.0954 | 16 | 2024-05-17 | 0.15 - 0.65 | 0.2 | Out |
Put | 2024-05-17 PUT at $10.0 | -0.2262 | 0.0952 | 0 | 2024-05-17 | 0.05 - 0.9 | 0.0 | Out |
Put | 2024-05-17 PUT at $12.5 | -0.5534 | 0.1455 | 0 | 2024-05-17 | 0.8 - 2.2 | 0.0 | In |
Put | 2024-05-17 PUT at $15.0 | -0.8824 | 0.0897 | 0 | 2024-05-17 | 2.85 - 3.8 | 0.0 | In |
Put | 2024-05-17 PUT at $17.5 | -0.7152 | 0.0595 | 0 | 2024-05-17 | 5.0 - 8.0 | 0.0 | In |
Put | 2024-05-17 PUT at $20.0 | -0.9349 | 0.0343 | 0 | 2024-05-17 | 6.6 - 10.0 | 0.0 | In |
Put | 2024-05-17 PUT at $22.5 | -0.8834 | 0.0368 | 0 | 2024-05-17 | 9.4 - 12.5 | 0.0 | In |
Put | 2024-05-17 PUT at $25.0 | -0.8915 | 0.0314 | 0 | 2024-05-17 | 11.9 - 15.0 | 0.0 | In |
Put | 2024-05-17 PUT at $30.0 | -0.8108 | 0.031 | 0 | 2024-05-17 | 17.7 - 20.0 | 0.0 | In |
Zentalis PharmaceuticalsL Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Zentalis PharmaceuticalsL Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
Zentalis Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zentalis PharmaceuticalsL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Zentalis PharmaceuticalsL Corporate Management
Elected by the shareholders, the Zentalis PharmaceuticalsL's board of directors comprises two types of representatives: Zentalis PharmaceuticalsL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zentalis. The board's role is to monitor Zentalis PharmaceuticalsL's management team and ensure that shareholders' interests are well served. Zentalis PharmaceuticalsL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zentalis PharmaceuticalsL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Bunker | CoFounder Officer | Profile | |
| Carrie MD | Chief Officer | Profile | |
| Adrian MD | Executive Development | Profile | |
| Mark Lackner | Chief Strategy | Profile | |
| Kimberly Freeman | Chief Officer | Profile | |
| Adam Levy | VP Relations | Profile |
Already Invested in Zentalis PharmaceuticalsLlc?
The danger of trading Zentalis PharmaceuticalsLlc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zentalis PharmaceuticalsL is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zentalis PharmaceuticalsL. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zentalis PharmaceuticalsL is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.